Cancer immunotherapies expert Allison set for Discovery Lecture
James Allison, PhD, whose work led to the development of cancer immunotherapies known as “checkpoint inhibitors,” will deliver the next Flexner Discovery Lecture on Thursday, March 8.
By Leigh MacMillan